Clinical Trial Update: CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle [Phase 1, Phase 2]

View source ↗

Summary

The trial evaluated carbon monoxide as a stimulant for mitochondrial biogenesis in human cardiac muscle in a Phase 1/2 study that was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Carbon Monoxide (carbon monoxide)

Snippet

Sponsor: John J Freiberger | Conditions: Cardiac Disease, Mitochondrial Biogenesis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-05-19